A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine
Advancements in next-generation sequencing and other -omics technologies are accelerating the detailed molecular characterization of individual patient tumors, and driving the evolution of precision medicine. Cancer is no longer considered a single disease, but rather, a diverse array of diseases wh...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fcell.2017.00083/full |
id |
doaj-6741549dc2f74eb1aa2e849ca5c0e299 |
---|---|
record_format |
Article |
spelling |
doaj-6741549dc2f74eb1aa2e849ca5c0e2992020-11-24T22:53:31ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2017-09-01510.3389/fcell.2017.00083291496A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision MedicineIzumi V. Hinkson0Izumi V. Hinkson1Tanja M. Davidsen2Juli D. Klemm3Ishwar Chandramouliswaran4Anthony R. Kerlavage5Warren A. Kibbe6Warren A. Kibbe7Center for Biomedical Informatics and Information Technology, National Cancer InstituteRockville, MD, United StatesScience and Technology Policy Fellowship Program, American Association for the Advancement of ScienceWashington, DC, United StatesCenter for Biomedical Informatics and Information Technology, National Cancer InstituteRockville, MD, United StatesCenter for Biomedical Informatics and Information Technology, National Cancer InstituteRockville, MD, United StatesOffice of Genomics and Advanced Technologies, National Institute of Allergy and Infectious DiseasesBethesda, MD, United StatesCenter for Biomedical Informatics and Information Technology, National Cancer InstituteRockville, MD, United StatesCenter for Biomedical Informatics and Information Technology, National Cancer InstituteRockville, MD, United StatesDepartment of Biostatistics and Bioinformatics, Duke University School of MedicineDurham, NC, United StatesAdvancements in next-generation sequencing and other -omics technologies are accelerating the detailed molecular characterization of individual patient tumors, and driving the evolution of precision medicine. Cancer is no longer considered a single disease, but rather, a diverse array of diseases wherein each patient has a unique collection of germline variants and somatic mutations. Molecular profiling of patient-derived samples has led to a data explosion that could help us understand the contributions of environment and germline to risk, therapeutic response, and outcome. To maximize the value of these data, an interdisciplinary approach is paramount. The National Cancer Institute (NCI) has initiated multiple projects to characterize tumor samples using multi-omic approaches. These projects harness the expertise of clinicians, biologists, computer scientists, and software engineers to investigate cancer biology and therapeutic response in multidisciplinary teams. Petabytes of cancer genomic, transcriptomic, epigenomic, proteomic, and imaging data have been generated by these projects. To address the data analysis challenges associated with these large datasets, the NCI has sponsored the development of the Genomic Data Commons (GDC) and three Cloud Resources. The GDC ensures data and metadata quality, ingests and harmonizes genomic data, and securely redistributes the data. During its pilot phase, the Cloud Resources tested multiple cloud-based approaches for enhancing data access, collaboration, computational scalability, resource democratization, and reproducibility. These NCI-led efforts are continuously being refined to better support open data practices and precision oncology, and to serve as building blocks of the NCI Cancer Research Data Commons.http://journal.frontiersin.org/article/10.3389/fcell.2017.00083/fullgenomicsproteomicsimagingbig datacancerprecision medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Izumi V. Hinkson Izumi V. Hinkson Tanja M. Davidsen Juli D. Klemm Ishwar Chandramouliswaran Anthony R. Kerlavage Warren A. Kibbe Warren A. Kibbe |
spellingShingle |
Izumi V. Hinkson Izumi V. Hinkson Tanja M. Davidsen Juli D. Klemm Ishwar Chandramouliswaran Anthony R. Kerlavage Warren A. Kibbe Warren A. Kibbe A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine Frontiers in Cell and Developmental Biology genomics proteomics imaging big data cancer precision medicine |
author_facet |
Izumi V. Hinkson Izumi V. Hinkson Tanja M. Davidsen Juli D. Klemm Ishwar Chandramouliswaran Anthony R. Kerlavage Warren A. Kibbe Warren A. Kibbe |
author_sort |
Izumi V. Hinkson |
title |
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine |
title_short |
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine |
title_full |
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine |
title_fullStr |
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine |
title_full_unstemmed |
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine |
title_sort |
comprehensive infrastructure for big data in cancer research: accelerating cancer research and precision medicine |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cell and Developmental Biology |
issn |
2296-634X |
publishDate |
2017-09-01 |
description |
Advancements in next-generation sequencing and other -omics technologies are accelerating the detailed molecular characterization of individual patient tumors, and driving the evolution of precision medicine. Cancer is no longer considered a single disease, but rather, a diverse array of diseases wherein each patient has a unique collection of germline variants and somatic mutations. Molecular profiling of patient-derived samples has led to a data explosion that could help us understand the contributions of environment and germline to risk, therapeutic response, and outcome. To maximize the value of these data, an interdisciplinary approach is paramount. The National Cancer Institute (NCI) has initiated multiple projects to characterize tumor samples using multi-omic approaches. These projects harness the expertise of clinicians, biologists, computer scientists, and software engineers to investigate cancer biology and therapeutic response in multidisciplinary teams. Petabytes of cancer genomic, transcriptomic, epigenomic, proteomic, and imaging data have been generated by these projects. To address the data analysis challenges associated with these large datasets, the NCI has sponsored the development of the Genomic Data Commons (GDC) and three Cloud Resources. The GDC ensures data and metadata quality, ingests and harmonizes genomic data, and securely redistributes the data. During its pilot phase, the Cloud Resources tested multiple cloud-based approaches for enhancing data access, collaboration, computational scalability, resource democratization, and reproducibility. These NCI-led efforts are continuously being refined to better support open data practices and precision oncology, and to serve as building blocks of the NCI Cancer Research Data Commons. |
topic |
genomics proteomics imaging big data cancer precision medicine |
url |
http://journal.frontiersin.org/article/10.3389/fcell.2017.00083/full |
work_keys_str_mv |
AT izumivhinkson acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT izumivhinkson acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT tanjamdavidsen acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT julidklemm acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT ishwarchandramouliswaran acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT anthonyrkerlavage acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT warrenakibbe acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT warrenakibbe acomprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT izumivhinkson comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT izumivhinkson comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT tanjamdavidsen comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT julidklemm comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT ishwarchandramouliswaran comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT anthonyrkerlavage comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT warrenakibbe comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine AT warrenakibbe comprehensiveinfrastructureforbigdataincancerresearchacceleratingcancerresearchandprecisionmedicine |
_version_ |
1725663055227912192 |